Skip to main content
. 2006 Oct 3;95(9):1202–1211. doi: 10.1038/sj.bjc.6603369

Figure 6.

Figure 6

Cytotoxicity of EZH2-specific cytotoxic T-cell clones 691, 696 and 480 derived from normal donor 001 and HCC patient 002 against (A) HLA-A0201-matched primary human fibroblasts infected with recombinant adenoviruses (either RAdEZH2 or RAdControl) and (B) the HLA-A0201-positive breast carcinoma cell line MCF7. Chromium release assays employed 2.5 × 103 target cells well−1. Effector : target cell ratios and additions of either IFN-γ or monoclonal antibody BB7.2 are indicated on individual graphs. The results shown are means of triplicate wells and standard errors were less than 10%.